Galmed Pharmaceuticals Ltd. (GLMD) — Net Income

Annual figures by fiscal year, from SEC filings.

2012: -$3.15M2013: -$17.48M2014: -$9.10M2015: -$10.62M2016: -$16.95M2017: -$12.30M2018: -$9.86M2019: $20.50M2020: -$28.80M2021: $32.40M2022: $17.90M2023: $10.30M2024: $7.50M2025: $6.90M$6.90M
2012Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$6.90M-8.0%
2024$7.50M-27.2%
2023$10.30M-42.5%
2022$17.90M-44.8%
2021$32.40M+212.5%
2020-$28.80M-240.5%
2019$20.50M+308.0%
2018-$9.86M+19.9%
2017-$12.30M+27.5%
2016-$16.95M-59.6%
2015-$10.62M-16.7%
2014-$9.10M+47.9%
2013-$17.48M-455.3%
2012-$3.15M